Back

Rapid Podocyte ablation Causes Acute Renal Tubule Cell Necrosis and Interstitial Fibrosis

Chen, Y.; Islamuddin, M.; Ding, X.; Evangelista, J.; Salomon, A.; Hidalgo, G. M.; Liu, S.; Midkiff, C. C.; Ryousuke, S.; Zhuo, J. L.; Kolls, J.; Batuman, V.; Bhargava, R.; Blair, R. V.; Qin, X.

2026-03-23 pathology
10.64898/2026.03.19.712955 bioRxiv
Show abstract

It remains unclear whether podocyte loss directly causes acute renal tubular cell (RTC) damage and interstitial fibrosis, thereby leading to renal failure. Here, we applied intermedilysin (ILY)-mediated human CD59 (hCD59) cell ablation to generate an acute, specific podocyte-ablation mouse model. Cre-induced hCD59 transgenics (ihCD59) were crossed with Nphs2Cre to generate ihCD59+/-/Nphs2Cre+/- mice. The specific and rapid podocyte-ablation mediated by ILY injection directly caused RTC necrosis, leading to renal failure and even death within 2-3 days in a dose-dependent manner. Treating mice that received an ILY lethal dose with peritoneal dialysis or administering a non-lethal dose, we extended their survival beyond six weeks and found that mice developed interstitial fibrosis and glomerulosclerosis with persistent proteinuria and tubule damage. Podocyte-ablation caused massive disruption of glomerular function at week 1, and then partial recovery by week 2. Genes and pathways of TLRs and apoptosis, and mitochondrial functions were respectively upregulated and downregulated in both ablated-podocyte mouse and biopsied-glomerulonephritis patient kidney samples. Together, this rapid podocyte-ablation causes acute RTC necrosis that progresses to interstitial fibrosis in this mouse model, which is applicable for dissecting mechanisms underlying podocyte injury-mediated tubular damage and glomerular repair, with the potential to reveal novel therapeutic targets for kidney diseases.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Protein & Cell
25 papers in training set
Top 0.1%
18.5%
2
Journal of Clinical Investigation
164 papers in training set
Top 0.1%
8.4%
3
Cell Discovery
54 papers in training set
Top 0.5%
8.4%
4
JCI Insight
241 papers in training set
Top 0.4%
6.8%
5
eLife
5422 papers in training set
Top 13%
6.3%
6
Kidney International
25 papers in training set
Top 0.1%
4.3%
50% of probability mass above
7
Nature Communications
4913 papers in training set
Top 40%
3.6%
8
Theranostics
33 papers in training set
Top 0.2%
3.6%
9
Journal of the American Society of Nephrology
52 papers in training set
Top 0.3%
3.2%
10
Molecular Therapy
71 papers in training set
Top 0.9%
2.7%
11
Kidney360
22 papers in training set
Top 0.3%
2.6%
12
Advanced Science
249 papers in training set
Top 9%
2.1%
13
Kidney International Reports
14 papers in training set
Top 0.2%
1.9%
14
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.7%
15
Scientific Reports
3102 papers in training set
Top 67%
1.2%
16
Cell Reports
1338 papers in training set
Top 28%
1.2%
17
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 1%
1.1%
18
Cells
232 papers in training set
Top 5%
0.9%
19
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.9%
20
PLOS ONE
4510 papers in training set
Top 66%
0.8%
21
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.9%
0.8%
22
National Science Review
22 papers in training set
Top 2%
0.8%
23
Science Bulletin
22 papers in training set
Top 0.9%
0.7%
24
Transplantation
13 papers in training set
Top 0.4%
0.7%
25
Gastroenterology
40 papers in training set
Top 2%
0.7%
26
Cell Stem Cell
57 papers in training set
Top 3%
0.6%
27
Clinical and Translational Medicine
30 papers in training set
Top 1%
0.6%
28
The American Journal of Pathology
31 papers in training set
Top 0.7%
0.6%
29
Cell Reports Medicine
140 papers in training set
Top 9%
0.6%